From Verify.Wiki
Jump to: navigation, search

Affymax, Inc. is a biopharmaceutical company previously committed to developing novel drugs to improve the treatment of serious and often life-threatening conditions. Our vision was to become a leader in the nephrology and specialty care space by delivering innovative therapeutic offerings to patients and healthcare providers before a nationwide voluntary recall of OMONTYS® (peginesatide) Injection in February 2013. In March 2013 Affymax commenced a review of strategic alternatives. 

Type Public / Private



Top 5 Recent Tweets

January 11, 2020ElementaryValueNew blog post is up. Another NOL stub for all you fans of special situations. Affymax Inc. (AFFY) - A Couchman co…
January 17, 2020WeekHeraldAffymax $AFFY Shares Pass Above 200 Day Moving Average of $0.02
January 16, 2020dakotafinancialAffymax $AFFY Share Price Passes Above 200-Day Moving Average of $0.02

Top 5 Recent News Headlines

Top 5 Lifetime Tweets

Top 5 Lifetime News Headlines

Verification history